98%
921
2 minutes
20
Objectives: Understanding admission trends and causes is essential for optimal healthcare allocation and targeted interventions to prevent hospitalizations. This study investigates hospital admissions proportions and primary causes among patients with the following neurological conditions: Brain tumors (BT), motor neuron disease (MND), multiple sclerosis (MS), Parkinson's disease (PD), spinal cord injury (SCI), traumatic brain injury (TBI), stroke, cerebral palsy (CP).
Methods: We conducted a retrospective analysis using the National Inpatient Sample (2003-2014), identifying patients of all ages with validated ICD-9-CM codes for these neurological conditions in any diagnostic position. Admission causes were identified using Clinical Classifications Software for Diagnosis Codes. Weighted proportions of admission and top three causes of admissions were calculated for each diagnosis.
Results: The eight neurological conditions accounted for 8.11 % of all admissions in 2003, increasing to 9.37 % in 2014. Admissions for all conditions, except PD, increased proportionally. Stroke showed the largest absolute increase (13.62 %). For BT, MND, MS, SCI and TBI, the top cause of admission remained the neurological condition itself, but this percentage decreased over time. The top cause of admission changed from epilepsy/convulsions (2003-2012) for CP, and pneumonia (2003-2008) for PD, to septicemia for both conditions in subsequent years. Notably, from 2011 to 2014 septicemia was among the top three causes of all hospital admissions across diagnoses, except for BT and TBI.
Discussion: Seven of the conditions of interest had one or more top causes of admission that were potentially preventable. Further emphasis on infection prevention is likely to reduce the occurrence of admission in those with neurological conditions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clineuro.2025.109042 | DOI Listing |
Neuro Endocrinol Lett
September 2025
Department of Pediatric Neurology, Cukurova University Faculty of Medicine, Adana, Turkey.
Objective: It is important to raise awareness of the nutritional problems that can be overlooked during the follow-up visits with children who suffer from neuromuscular diseases, as these dietary differences may lead to additional neurological and systemic problems and impair the quality of life of the patient. The aim of this study was to evaluate the nutritional status of children with neuromuscular disorders and to prevent possible complications by recognizing possible nutritional problems in advance.
Methods: Patients who applied to the outpatient clinic at Cukurova University, Faculty of Medicine, Department of Pediatric Neurology beginning in April 2022 with a neuromuscular disorder diagnosis were followed up with and were included in the study.
Neurol Neuroimmunol Neuroinflamm
November 2025
Department of Neurology, UC Davis Medical Center, Sacramento, CA.
Objectives: Complement factor I (CFI) deficiency is a rare condition that can present with fulminant relapsing CNS autoinflammation. In this report, we highlight the utility of genetic testing in unexplained CNS autoinflammation.
Methods: This case report describes a young adult with partial CFI deficiency, presenting with acute hemorrhagic leukoencephalitis and longitudinally extensive transverse myelitis.
JMIR Hum Factors
September 2025
Villa Beretta Rehabilitation Center, Costa Masnaga, Italy.
Background: Telerehabilitation is a promising solution to provide continuity of care. Most existing telerehabilitation platforms focus on rehabilitating upper limbs, balance, and cognitive training, but exercises improving cardiovascular fitness are often neglected.
Objective: The objective of this study is to evaluate the acceptability and feasibility of a telerehabilitation intervention combining cognitive and aerobic exercises.
Arq Gastroenterol
September 2025
The Japanese Society of Internal Medicine, Editorial Department, Tokyo, Japan.
Background: This study aims to analyze research trends and emerging insights into gut microbiota studies from 2015 to 2024 through bibliometric analysis techniques. By examining bibliographic data from the Web of Science (WoS) Core Collection, it seeks to identify key research topics, evolving themes, and significant shifts in gut microbiota research. The study employs co-occurrence analysis, principal component analysis (PCA), and burst detection analysis to uncover latent patterns and the development trajectory of this rapidly expanding field.
View Article and Find Full Text PDFSci Transl Med
September 2025
Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
Oligodendrocytes, the myelinating cells of the central nervous system (CNS), are essential for the formation of myelin sheaths and pivotal for maintaining axonal integrity and conduction. Disruption of these cells and the myelin sheaths they produce is a hallmark of demyelinating conditions like multiple sclerosis or those resulting from certain drug side effects, leading to profound neurological impairments. In this study, we created a human brain organoid comprising neurons, astrocytes, and myelinating oligodendrocytes.
View Article and Find Full Text PDF